IL6 and rheumatoid arthritis: Increased levels of pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α in the synovial fluid of RA patients can lead to the production of matrix metalloproteinases, contributing to the deterioration of joint cartilage and bone [4].